Kezar Life Sciences (KZR) Assets Average (2021 - 2025)
Historic Assets Average for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $103.4 million.
- Kezar Life Sciences' Assets Average fell 3987.07% to $103.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.4 million, marking a year-over-year decrease of 3987.07%. This contributed to the annual value of $183.0 million for FY2024, which is 2973.98% down from last year.
- Per Kezar Life Sciences' latest filing, its Assets Average stood at $103.4 million for Q3 2025, which was down 3987.07% from $117.2 million recorded in Q2 2025.
- In the past 5 years, Kezar Life Sciences' Assets Average ranged from a high of $311.1 million in Q3 2022 and a low of $103.4 million during Q3 2025
- Its 5-year average for Assets Average is $207.1 million, with a median of $199.9 million in 2024.
- Its Assets Average has fluctuated over the past 5 years, first soared by 12999.32% in 2022, then tumbled by 3987.07% in 2025.
- Over the past 5 years, Kezar Life Sciences' Assets Average (Quarter) stood at $174.4 million in 2021, then skyrocketed by 73.25% to $302.2 million in 2022, then dropped by 22.14% to $235.3 million in 2023, then crashed by 34.38% to $154.4 million in 2024, then crashed by 33.01% to $103.4 million in 2025.
- Its last three reported values are $103.4 million in Q3 2025, $117.2 million for Q2 2025, and $135.0 million during Q1 2025.